Filtros de búsqueda

Lista de obras de

A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection

scientific article published on 14 May 2019

Different hepatitis B carrier categories need different management strategies in case of immunosuppressive chemotherapeutic regimens ⬇️

artículo científico publicado el 27 de abril de 2011

Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study

artículo científico publicado en 2016

Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients ⬇️

artículo científico publicado el 13 de diciembre de 2010

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets

artículo científico publicado en 2018

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.

artículo científico publicado en 2015

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients

scientific article published on 14 August 2019

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection

artículo científico publicado en 2020

Moyamoya disease as a possible cause of neurological impairment following liver transplantation for Wilson's disease ⬇️

artículo científico publicado el 1 de marzo de 2011

Nasogastric or nasointestinal feeding in severe acute pancreatitis ⬇️

artículo científico publicado el 7 de agosto de 2010

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

artículo científico publicado en 2017

[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda